271. Ankylosing spondylitis Clinical trials / Disease details

Clinical trials : 574 / Drugs : 359 - (DrugBank : 68) / Drug target genes : 41 - Drug target pathways : 146

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03411798 (ClinicalTrials.gov)	December 15, 2017	14/12/2017	Sequential Application of Yisaipu® and DMARDs in Treating Mild-to-Moderate AS	Sequential Application of Yisaipu® and Disease Modifying Anti-Rheumatic Drugs (DMARDs) in Treating Mild-to-Moderate Ankylosing Spondylitis: the Mid-term Follow-up Result	Ankylosing Spondylitis	Drug: Yisaipu ®	Nanfang Hospital of Southern Medical University	NULL	Completed	N/A	N/A	All	76	Phase 4	China
2	NCT04345458 (ClinicalTrials.gov)	March 6, 2014	3/4/2020	Safety and Efficacy Study of Prefilled Liquid Etanercept(Yisaipu) for Active Ankylosing Spondylitis	Safety and Efficacy of Prefilled Liquid Etanercept(Yisaipu) for Active Ankylosing Spondylitis on the Basis of NSAID Therapy: A Multicenter Randomized, Double-blind, Parallel Group Phase III Trial	Ankylosing Spondylitis	Drug: prefilled liquid etanercept(Yisaipu);Drug: lyophilized etanercept powder(Yisaipu)	Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.	NULL	Completed	18 Years	65 Years	All	640	Phase 3	China